Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance
Open Access
- 30 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (1) , e4308
Abstract
Most information on invasive Staphylococcus aureus infections comes from temperate countries. There are considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.Keywords
This publication has 25 references indexed in Scilit:
- Rapid Detection of the Pandemic Methicillin-Resistant Staphylococcus aureus Clone ST 239, a Dominant Strain in Asian HospitalsJournal of Clinical Microbiology, 2008
- Epidemiology and prevention of valvular heart diseases and infective endocarditis in AfricaHeart, 2007
- Changing Epidemiology of Pediatric Staphylococcus aureus Bacteremia in Denmark From 1971 Through 2000The Pediatric Infectious Disease Journal, 2007
- Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000Clinical Microbiology and Infection, 2007
- Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UKJournal of Hospital Infection, 2007
- Staphylococcus aureus EndocarditisJAMA, 2005
- Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureusThe Pediatric Infectious Disease Journal, 2004
- A Prospective Multicenter Study of Staphylococcus aureus BacteremiaMedicine, 2003
- Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2003
- Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortalityInternal Medicine Journal, 2001